A phase I study of intravenous (IV) milataxel in combination with carboplatin in adult patients with advanced malignant solid tumors

被引:0
|
作者
Flood, W. A. [1 ,2 ]
Lewis, L. D. [1 ,2 ]
机构
[1] Penn State Hershey Canc Inst, Hershey, PA USA
[2] Dartmouth Med Sch, Lebanon, NH USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13525
引用
收藏
页数:2
相关论文
共 50 条
  • [21] A phase I study of intravenous artesunate (IV AS) in patients with solid tumors.
    Deeken, John F.
    Wang, Hongkun
    Smaglo, Brandon George
    Hwang, Jimmy J.
    He, Aiwu Ruth
    Weiner, Louis M.
    Marshall, John
    Giaccone, Giuseppe
    Liu, Stephen V.
    Luecht, Jim
    Urso, Christina
    Spiegel, Jay Y.
    Cheema, Amrita
    Pishvaian, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Gemcitabine and carboplatin combination in advanced solid tumors: A phase I trial.
    Tassinari, D
    Pasini, G
    Arcangeli, V
    Panzini, I
    Drudi, G
    Gianni, L
    Oliverio, G
    Sartori, S
    Fochessati, F
    ANNALS OF ONCOLOGY, 2000, 11 : 141 - 141
  • [23] A Phase I and Pharmacokinetic Study of Ixabepilone in Combination with Carboplatin in Patients with Advanced Solid Malignancies
    Plummer, Ruth
    Woll, Penella
    Fyfe, David
    Boddy, Alan V.
    Griffin, Melanie
    Hewitt, Paula
    Carmichael, James
    Namouni, Fouad
    Cohen, Marvin
    Verrill, Mark
    CLINICAL CANCER RESEARCH, 2008, 14 (24) : 8288 - 8294
  • [24] Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors
    Vidal, Laura
    Magem, Margarita
    Barlow, Clare
    Pardo, Beatriz
    Florez, Amalia
    Montes, Ana
    Garcia, Margarita
    Judson, Ian
    Lebedinsky, Claudia
    Kaye, Stan B.
    Salazar, Ramon
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 616 - 628
  • [25] Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors
    Laura Vidal
    Margarita Magem
    Clare Barlow
    Beatriz Pardo
    Amalia Florez
    Ana Montes
    Margarita Garcia
    Ian Judson
    Claudia Lebedinsky
    Stan B. Kaye
    Ramón Salazar
    Investigational New Drugs, 2012, 30 : 616 - 628
  • [26] Phase I study of combination topotecan and carboplatin in pediatric solid tumors
    Athale, UH
    Stewart, C
    Kuttesch, JF
    Moghrabi, A
    Meyer, W
    Pratt, C
    Gajjar, A
    Heideman, RL
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) : 88 - 95
  • [27] Phase I Study of Pazopanib in Combination with Paclitaxel and Carboplatin Given Every 21 Days in Patients with Advanced Solid Tumors
    Burris, Howard A., III
    Dowlati, Afshin
    Moss, Rebecca A.
    Infante, Jeffrey R.
    Jones, Suzanne F.
    Spigel, David R.
    Levinson, Kelly T.
    Lindquist, Diana
    Gainer, Shelby D.
    Dar, Mohammed M.
    Suttle, A. Benjamin
    Ball, Howard A.
    Tan, Antoinette R.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (08) : 1820 - 1828
  • [28] Phase I study of oral CI-994 in combination with carboplatin and paclitaxel in the treatment of patients with advanced solid tumors
    Pauer, LR
    Olivares, J
    Cunningham, C
    Williams, A
    Grove, W
    Kraker, G
    Olson, S
    Nemunaitis, J
    CANCER INVESTIGATION, 2004, 22 (06) : 886 - 896
  • [29] Phase IB study of eribulin mesylate in combination with carboplatin in patients with advanced solid tumors.
    Swami, U.
    Petrylak, D. P.
    Raftopoulos, H.
    Shuster, D. E.
    Wang, G.
    Kumar, V.
    Martinez, G.
    Goel, S.
    Alsner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Phase I Dose-Escalation Study of Intravenous Aflibercept in Combination with Docetaxel in Patients with Advanced Solid Tumors
    Isambert, Nicolas
    Freyer, Gilles
    Zanetta, Sylvie
    You, Benoit
    Fumoleau, Pierre
    Falandry, Claire
    Favier, Laure
    Assadourian, Sylvie
    Soussan-Lazard, Karen
    Ziti-Ljajic, Samira
    Trillet-Lenoir, Veronique
    CLINICAL CANCER RESEARCH, 2012, 18 (06) : 1743 - 1750